IRB information regarding COVID-19
The guidelines below apply ONLY to studies overseen by the NIH IRB. If the study is overseen by a non-NIH IRB, you must follow the policies of that IRB.
For all sponsored studies, you must receive sponsor approval for any changes to the protocol.
March 11, 2020
NIH IRB Guidelines for protocol deviations during COVID-19 outbreak
March 12, 2020
Instructions to be followed for treating a patient with a study drug at a non-study location
March 30, 2020
IRB continued operations and facilitation of the rapid review of any human subjects research related to the SARS-CoV-2 pandemic.
March 31, 2020
OHSRP Procedures Related to COVID-19 Research and the PREP Act
April 7, 2020
Important information regarding COVID-19 related research
June 01, 2020
Informed Consent During the COVID-19 Outbreak
Overview
Content Tools
ThemeBuilder